|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 04/11/14 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 03/11/14 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 06/03/2023 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 31/05/2011 |
Stephen Street
PRN | Corporate Officer/Principal | 65 | 18/06/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 19/02/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.84% | +1.37% | +11.93% | +82.30% | 54.55B | |
| -1.13% | +0.77% | +10.21% | +101.73% | 53.59B | |
| +2.01% | +0.81% | +27.84% | +57.41% | 44.75B | |
| +2.18% | -3.12% | +18.17% | +100.64% | 41.62B | |
| +0.16% | -3.50% | +222.31% | +921.72% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.37% | -0.42% | +51.90% | +162.35% | 42.27B | |
| Weighted average by Cap. | +3.05% | -0.29% | +47.34% | +161.01% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
